<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Reverse Alzheimers with Dr Dave Jenkins</title>
  <description>What if you could know 20 YEARS before symptoms appear whether you're heading for Alzheimer's? And what if there was a proven way to reverse early cognitive decline? In this episode, I sit down with my dear friend Dr. Dave Jenkins — the leading Dr. Dale Bredesen Protocol practitioner in the Southern Hemisphere — to unpack the p-Tau 217 blood test revolution and the stunning results from Bredesen's latest randomised controlled trial. Dr. Dave breaks down how a simple finger-prick blood test can now detect the Alzheimer's process with 95% certainty up to TWO DECADES before memory symptoms begin. This isn't diagnosing Alzheimer's — it's diagnosing the process, which means you have 20 years to intervene. We dive into Bredesen's 2024 multi-site RCT showing the ReCODE precision medicine protocol is 6–7x MORE POWERFUL than the best Alzheimer's drug currently available in America (lecanemab) — a drug with devastating side effects including brain bleeds and even death. Dr. Dave shares real clinical insights from his Bali longevity practice including the 30–60 &amp;quot;holes in the roof&amp;quot; driving cognitive decline, cutting-edge peptides (Semax, Selank, Cerebrolysin, Dihexa), bioregulators, and his personal experience with Klotho gene therapy that took his memory scores from the 70th to the 97th percentile in just 6 weeks. This is essential listening for anyone with a family history of Alzheimer's, anyone watching a loved one decline, and anyone who wants to take brain health seriously BEFORE it becomes a crisis. ⏰ CHAPTERS: [to be generated after edit] 🧠 IN THIS EPISODE: ✅ The p-Tau 217 blood test — detect Alzheimer's 20 years early ✅ Bredesen's RCT: 6–7x more powerful than lecanemab ✅ The BrainScan panel: p-Tau 217, NfL, GFAP explained ✅ Why amyloid drugs chase the smoke, not the fire ✅ The 30–60 &amp;quot;holes in the roof&amp;quot; driving cognitive decline ✅ APOE4 genetics — who needs to pay attention ✅ Peptides for brain health (Semax, Selank, Cerebrolysin, Dihexa) ✅ Klotho gene therapy — 70th to 97th percentile memory scores ✅ Dr. Dave's Bali longevity program at Ravivo Resorts ✅ How NZ/AU listeners can access testing remotely 🔗 CONNECT WITH DR. DAVE JENKINS: 🌐 youngerbyscience.com 🌐 endalzheimers.com.au 🔗 RESOURCES MENTIONED: 🧬 BrainScan p-Tau 217 Test — neurocode.com 🧠 Dr. Dale Bredesen / Apollo Health — apollohealthco.com 📄 Bredesen 2025 RCT — apollohealthco.com/rct-2025 💊 EPISODE SPONSOR: MitoSynergy BioCopper1 — Get 10% off at mitosynergy.com/lisatamati The patented copper nicotinate chelate I take daily for mitochondrial ATP production, mental clarity, and sustained focus. 🔗 WORK WITH LISA: 🌐 lisatamati.com 🛒 shop.lisatamati.com 🧬 aevumlabs.co.nz 🎙️ Pushing the Limits Podcast — lisatamati.com/podcast 📧 support@lisatamati.com 📱 FOLLOW LISA: Instagram: @lisatamati Facebook: @lisatamati &amp;amp;nbsp; </description>
  <author_name>Pushing The Limits</author_name>
  <author_url>https://www.lisatamati.com</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/40808855/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/200641290</thumbnail_url>
</oembed>
